CN118909162A - Silicon-based resin compound and preparation method and application thereof - Google Patents
Silicon-based resin compound and preparation method and application thereof Download PDFInfo
- Publication number
- CN118909162A CN118909162A CN202410962333.6A CN202410962333A CN118909162A CN 118909162 A CN118909162 A CN 118909162A CN 202410962333 A CN202410962333 A CN 202410962333A CN 118909162 A CN118909162 A CN 118909162A
- Authority
- CN
- China
- Prior art keywords
- compound
- resin
- silicon
- based resin
- reaction
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
- A61K51/06—Macromolecular compounds, carriers being organic macromolecular compounds, i.e. organic oligomeric, polymeric, dendrimeric molecules
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08F—MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
- C08F8/00—Chemical modification by after-treatment
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08F—MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
- C08F8/00—Chemical modification by after-treatment
- C08F8/42—Introducing metal atoms or metal-containing groups
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Polymers & Plastics (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Physics & Mathematics (AREA)
- Optics & Photonics (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
Abstract
Description
技术领域Technical Field
本发明涉及硅基树脂类化合物领域,具体而言,涉及一种硅基树脂类化合物及其制备方法和应用。The present invention relates to the field of silicon-based resin compounds, and in particular to a silicon-based resin compound and a preparation method and application thereof.
背景技术Background Art
放射性标记技术在核医学影像、放射性示踪研究和肿瘤靶向治疗等领域具有重要应用。这些技术利用放射性同位素(如碘-123、碘-124、碘-125、碘-131和砹-211)标记特定药物或生物分子,以便在医学成像中清晰显示病变部位或在治疗中直接作用于肿瘤细胞。然而,现有的放射性碘/砹标记方法存在一些局限性,在反应方法本身上存在包括反应条件苛刻、放射化学产率低、副反应多和需要耗时的高效液相色谱分离等问题,在应用方面则存在适用范围较窄及体内脱碘的问题。Radioactive labeling technology has important applications in nuclear medicine imaging, radioactive tracer research, and targeted tumor therapy. These technologies use radioactive isotopes (such as iodine-123, iodine-124, iodine-125, iodine-131, and astatine-211) to label specific drugs or biomolecules so that lesions can be clearly displayed in medical imaging or directly act on tumor cells during treatment. However, existing radioactive iodine/astatine labeling methods have some limitations. The reaction method itself has problems such as harsh reaction conditions, low radiochemical yield, many side reactions, and time-consuming high-performance liquid chromatography separation. In terms of application, there are problems such as a narrow scope of application and in vivo deiodination.
现有的放射性碘/砹标记技术主要产品和方法包括:The main products and methods of existing radioactive iodine/astatine labeling technology include:
直接标记法:碘的直接标记法是较为常用的放射性碘标记方法,标记原理如下式所示:Direct labeling method: Direct labeling method of iodine is a more commonly used radioactive iodine labeling method. The labeling principle is shown as follows:
其标记过程主要涉及亲电取代反应,是*I-在氧化剂的作用下发生氧化反应生成*I2或*I+,然后亲电取代靶向分子或药物中芳香族化合物特定基团(如蛋白、多肽中含有的酪氨酸、苯丙氨酸、色氨酸和组氨酸,苯环、苯酚环等活性环)上的氢原子。直接标记法具有放化产率高、操作简便、试剂便宜等优点。然而该方法使用的原料是一种强氧化剂,有可能对敏感待标记物(比如生物活性不稳定的受体、激素等)造成破坏,比如色氨酸肽键的断裂、结构中硫醇或硫醚基的氧化导致待标记物生物活性丧失等。The labeling process mainly involves an electrophilic substitution reaction, in which *I- undergoes an oxidation reaction under the action of an oxidant to generate *I 2 or *I + , and then electrophilically replaces hydrogen atoms on specific groups of aromatic compounds in target molecules or drugs (such as tyrosine, phenylalanine, tryptophan and histidine contained in proteins and polypeptides, benzene rings, phenol rings and other active rings). The direct labeling method has the advantages of high radiochemical yield, simple operation, and cheap reagents. However, the raw material used in this method is a strong oxidant, which may cause damage to sensitive labeled substances (such as receptors and hormones with unstable biological activity), such as the breakage of tryptophan peptide bonds, oxidation of thiol or thioether groups in the structure, resulting in loss of biological activity of the labeled substance, etc.
间接标记法:间接标记法是相对于将待标记物与放射性核素直接偶联的直接标记法而言,该方法大多通过中间体或前体物质先与药物或生物分子结合,再进行放射性碘的标记,需要进行至少两步的反应,获得结构为“放射性核素十辅助基团十靶向分子或药物”的标记物,标记原理如下式所示。Indirect labeling method: Compared with the direct labeling method of directly coupling the object to be labeled with the radioactive nuclide, the indirect labeling method is mostly through the intermediate or precursor material first combined with the drug or biological molecule, and then labeled with radioactive iodine. It requires at least two steps of reaction to obtain a marker with the structure of "radioactive nuclide + auxiliary group + targeting molecule or drug". The labeling principle is shown in the following formula.
这种方法虽然可以在一定程度上缓解直接标记法的极端反应条件,但仍然存在反应条件苛刻、放射化学产率低、副反应多等问题。间接放射性碘标记方法虽然可以拓宽待标记分子的范围,并在一定程度上改善标记产物稳定性的问题,但是其标记过程需要经历多个反应,放化产率是一个需要重点考虑的问题,并且常规方法制备放射性用的标记化合物的成本较高,且步骤繁琐。Although this method can alleviate the extreme reaction conditions of the direct labeling method to a certain extent, it still has problems such as harsh reaction conditions, low radiochemical yield, and many side reactions. Although the indirect radioiodine labeling method can broaden the range of molecules to be labeled and improve the stability of the labeled product to a certain extent, its labeling process requires multiple reactions, and the radiochemical yield is an issue that needs to be considered. In addition, the conventional method for preparing radiolabeled compounds is costly and the steps are cumbersome.
发明内容Summary of the invention
本发明要解决的第一个技术问题是提供一种硅基树脂类化合物,以解决常规放射性标记中存在的反应条件苛刻、放射化学产率低、副反应多以及容易对待标记物造成破坏的问题。The first technical problem to be solved by the present invention is to provide a silicon-based resin compound to solve the problems of harsh reaction conditions, low radiochemical yield, many side reactions and easy damage to the labeled substance in conventional radioactive labeling.
为了解决上述技术问题,本发明提供了一种硅基树脂类化合物,所述硅基树脂类化合物具有如式(I)所示结构:In order to solve the above technical problems, the present invention provides a silicon-based resin compound, wherein the silicon-based resin compound has a structure as shown in formula (I):
其中,P为树脂,且所述树脂为王氏树脂、氯甲基聚苯乙烯树脂、聚乙二醇树脂中的一种;X为-CH2CH2CH2-、-O(CH2CH2OCH2CH2)nCH2CH2-、-O(CH2CH2OCH2CH2)nCH2CH2O-中的一种,Y为-Me、-Et、-CH(CH3)2、-C(CH3)3中的一种,Ar为芳香烃类基团。Wherein, P is a resin, and the resin is one of Wang resin, chloromethyl polystyrene resin, and polyethylene glycol resin; X is one of -CH 2 CH 2 CH 2 -, -O(CH 2 CH 2 OCH 2 CH 2 ) n CH 2 CH 2 -, and -O(CH 2 CH 2 OCH 2 CH 2 ) n CH 2 CH 2 O-; Y is one of -Me, -Et, -CH(CH 3 ) 2 , and -C(CH 3 ) 3 ; and Ar is an aromatic hydrocarbon group.
相较于现有技术而言,本发明中的硅基树脂类化合物具有以下优点:Compared with the prior art, the silicone-based resin compound in the present invention has the following advantages:
1)本发明中的硅基树脂类化合物具备高效的放射性碘/砹结合能力,确保了标记反应的完全性和稳定性;1) The silicon-based resin compound of the present invention has a highly efficient radioactive iodine/astatine binding ability, ensuring the completeness and stability of the labeling reaction;
2)本发明中的硅基树脂类化合物具备优良的化学稳定性和生物相容性,适用于多种药物分子的标记;2) The silicon-based resin compound of the present invention has excellent chemical stability and biocompatibility and is suitable for labeling a variety of drug molecules;
3)本发明中的硅基树脂类化合物在实际应用时具备操作简便、条件温和的优点,适合于实验室和工业生产。3) The silicone-based resin compound of the present invention has the advantages of simple operation and mild conditions in practical application, and is suitable for laboratory and industrial production.
在一种可能的实施方式中,所述芳香烃类基团为 In one possible embodiment, the aromatic hydrocarbon group is
中的一种。 One of them.
在一种可能的实施方式中,所述硅基树脂类化合物的聚合度小于4000。In a possible implementation, the degree of polymerization of the silicon-based resin compound is less than 4000.
本发明要解决的第二个技术问题是,提供一种硅基树脂类化合物的制备方法,以解决常规制备方法步骤繁琐且成本高的问题。The second technical problem to be solved by the present invention is to provide a method for preparing a silicone-based resin compound to solve the problem that the conventional preparation method has complicated steps and high costs.
为了解决上述技术问题,本发明提供了一种所述的硅基树脂类化合物的制备方法,所述制备方法包括:In order to solve the above technical problems, the present invention provides a method for preparing the silicone-based resin compound, the preparation method comprising:
S1:取含P树脂的第一化合物经取代反应后得到第二化合物;S1: taking a first compound containing a P resin and subjecting it to a substitution reaction to obtain a second compound;
S2:将所述第二化合物经过至少一次的加成和/或取代加成反应后得到第三化合物;S2: subjecting the second compound to at least one addition and/or substitution addition reaction to obtain a third compound;
S3:将所述第三化合物与芳基卤代物经催化偶联反应后得到硅基树脂类化合物。S3: subjecting the third compound to a catalytic coupling reaction with an aromatic halide to obtain a silicon-based resin compound.
通过本发明上述的制备方法,提供了一种无需繁琐步骤、操作简单的硅基树脂类化合物的制备方法,克服了现有技术中放射性用的标记化合物的成本较高,且步骤繁琐的问题。The above-mentioned preparation method of the present invention provides a preparation method of silicone-based resin compounds without complicated steps and simple operation, which overcomes the problems of high cost and complicated steps of radioactive labeled compounds in the prior art.
在一种可能的实施方式中,所述第一化合物为氯甲基聚苯乙烯树脂,所述制备方法包括:In a possible embodiment, the first compound is chloromethyl polystyrene resin, and the preparation method comprises:
S1:树脂a与氯丙烯镁经取代反应得化合物b;S1: Resin a and magnesium chloride are reacted by substitution to obtain compound b;
S2:化合物b与硅烷经加成反应得化合物c;S2: Compound b reacts with silane to obtain compound c;
S3:化合物c与芳基卤代物经催化偶联反应得硅基树脂类化合物d,即为所述硅基树脂类化合物;S3: Compound c and an aromatic halide are subjected to a catalytic coupling reaction to obtain a silicon-based resin compound d, which is the silicon-based resin compound;
所述制备方法的反应过程如下:The reaction process of the preparation method is as follows:
式中,Z为Cl、Br、I中的一种,a为树脂a,b为化合物b,c为化合物c,d为硅基树脂类化合物d。In the formula, Z is one of Cl, Br, and I, a is resin a, b is compound b, c is compound c, and d is silicon-based resin compound d.
在一种可能的实施方式中,所述第一化合物为王氏树脂,所述制备方法包括:In a possible embodiment, the first compound is Wang resin, and the preparation method comprises:
S1:树脂e与三苯基溴化膦经取代反应得化合物f;S1: Resin e and triphenylphosphine bromide undergo substitution reaction to obtain compound f;
S2:化合物f与氯丙烯镁经取代加成反应得化合物g,化合物g与二烷基硅烷经加成反应得化合物h;S2: Compound f is reacted with magnesium chloride to obtain compound g through substitution addition reaction, and compound g is reacted with dialkylsilane to obtain compound h through addition reaction;
S3:化合物h与芳基卤代物经催化偶联反应得硅基树脂类化合物i;S3: Compound h and aryl halide undergo catalytic coupling reaction to obtain silicone-based resin compound i;
所述制备方法的反应过程如下:The reaction process of the preparation method is as follows:
式中,Z为Cl、Br、I中的一种,e为树脂e,f为反应物f,g为化合物g,h为化合物h,i为硅基树脂类化合物i。In the formula, Z is one of Cl, Br, and I, e is resin e, f is reactant f, g is compound g, h is compound h, and i is silicon-based resin compound i.
在一种可能的实施方式中,所述第一化合物为王氏树脂或氯甲基聚苯乙烯树脂,所述制备方法包括:In a possible embodiment, the first compound is Wang resin or chloromethyl polystyrene resin, and the preparation method comprises:
S1:树脂j与聚乙二醇经取代反应得化合物k;S1: Resin j and polyethylene glycol undergo substitution reaction to obtain compound k;
S2:化合物k与二氯亚砜经取代加成反应得化合物l;化合物l与氯丙烯镁经取代反应得化合物m;化合物m与二烷基硅烷经加成反应得化合物n;S2: Compound k is reacted with thionyl chloride to obtain compound l through substitution and addition reaction; compound l is reacted with magnesium chloride to obtain compound m through substitution reaction; compound m is reacted with dialkylsilane to obtain compound n through addition reaction;
S3:化合物n与芳基卤代物经催化偶联反应得硅基树脂类化合物o;其中n<4000,为树脂,选自:王氏树脂,氯甲基聚苯乙烯树脂,Z选自:Cl,Br,I,Y指代同权利要求1所述,Ar指代同权利要求1所述;S3: Compound n is reacted with an aromatic halide by catalytic coupling reaction to obtain a silicon-based resin compound o; wherein n<4000, is a resin selected from: Wang resin, chloromethyl polystyrene resin, Z is selected from: Cl, Br, I, Y refers to the same as described in claim 1, and Ar refers to the same as described in claim 1;
所述制备方法的反应过程如下:The reaction process of the preparation method is as follows:
式中,Z为Cl、Br、I中的一种,j为树脂j,k为化合物k,l为化合物l,m为化合物m,n为化合物n,o为硅基树脂类化合物o。In the formula, Z is one of Cl, Br, and I, j is resin j, k is compound k, l is compound l, m is compound m, n is compound n, and o is silicone-based resin compound o.
在一种可能的实施方式中,所述第一化合物为聚乙二醇树脂,所述制备方法包括:In a possible embodiment, the first compound is a polyethylene glycol resin, and the preparation method comprises:
S1:树脂p与二氯亚砜经取代反应得化合物q;S1: Resin p reacts with thionyl chloride to obtain compound q;
S2:化合物q与氯丙烯镁经取代加成反应得化合物r;化合物r与二烷基硅烷经取代反应得化合物s;S2: Compound q reacts with magnesium chloride to obtain compound r through substitution addition reaction; compound r reacts with dialkylsilane to obtain compound s through substitution reaction;
S3:化合物s与芳基卤代物经催化偶联反应得硅基树脂类化合物t;S3: Compound s reacts with an aromatic halide through a catalytic coupling reaction to obtain a silicone-based resin compound t;
所述制备方法的反应过程如下:The reaction process of the preparation method is as follows:
其中,P为聚乙二醇树脂,Z为Cl、Br、I中的一种,p为树脂p,q为化合物q,r为化合物r,s为化合物s,t为硅基树脂类化合物t。Wherein, P is polyethylene glycol resin, Z is one of Cl, Br, and I, p is resin p, q is compound q, r is compound r, s is compound s, and t is silicon-based resin compound t.
本发明要解决第三个技术问题是,提供上述硅基树脂类化合物的应用,以解决常规放射性标记中存在的反应条件苛刻、放射化学产率低、副反应多以及容易对待标记物造成破坏的问题。The third technical problem to be solved by the present invention is to provide the application of the above-mentioned silicon-based resin compounds to solve the problems of harsh reaction conditions, low radiochemical yield, many side reactions and easy damage to the labeled substance in conventional radioactive labeling.
为了解决上述问题,本发明提供了一种所述硅基树脂类化合物的应用,所述应用包括将该硅基树脂类化合物应用于放射性标记中。In order to solve the above problems, the present invention provides an application of the silicon-based resin compound, which includes applying the silicon-based resin compound to radioactive labeling.
在一种可能的实施方式中,所述应用包括将该硅基树脂类化合物应用于放射性标记中包括:将所述硅基树脂类化合物与131I/124I/127I/211At-发生亲电取代反应,制得芳基碘化合物或芳基砹化合物,随后,通过过滤分离标记产物,完成放射性标记。In a possible embodiment, the application includes applying the silicon-based resin compound to radioactive labeling, including: subjecting the silicon-based resin compound to an electrophilic substitution reaction with 131 I/ 124 I/ 127 I/ 211 At- to obtain an aryl iodine compound or an aryl astatine compound, and then separating the labeled product by filtration to complete the radioactive labeling.
在一种可能的实施方式中,所述反应的条件为:温度20-50℃,pH5.0-7.0。In a possible embodiment, the reaction conditions are: temperature 20-50° C., pH 5.0-7.0.
本发明中的硅基树脂类化合物的应用避开了传统标记方法的缺点,提供了一种硅基树脂类化合物的应用,特别适用于医学成像、靶向放射性治疗和生物学研究中的碘同位素和砹同位素标记;本发明中的含硅基树脂具有以下组分:有机硅聚合物作为基质,功能化的苯基硅烷作为活性位点,本发明的功能化基团包括但不限于烷基芳基硅烷,通过本发明的含硅基树脂,可在温和条件下、实现高效的放射性碘(如碘-124、碘-131)和砹-211标记反应。The application of the silicon-based resin compound in the present invention avoids the shortcomings of the traditional labeling method and provides an application of the silicon-based resin compound, which is particularly suitable for iodine isotope and astatine isotope labeling in medical imaging, targeted radiotherapy and biological research; the silicon-based resin in the present invention has the following components: an organic silicon polymer as a matrix, a functionalized phenylsilane as an active site, and the functionalized group of the present invention includes but is not limited to alkylaryl silane. Through the silicon-based resin of the present invention, efficient radioactive iodine (such as iodine-124, iodine-131) and astatine-211 labeling reactions can be achieved under mild conditions.
通过本发明中硅基树脂类化合物的应用,可以显著提高放射性碘/砹标记的放射化学产率,降低副反应的发生,并简化后续分离纯化步骤,直接获得高纯度的标记产物,该应用的技术可广泛应用于核医学影像、放射性示踪、肿瘤靶向治疗等领域,显著提升了相关产品的性能和临床应用价值。By using the silicon-based resin compounds in the present invention, the radiochemical yield of radioactive iodine/astatine labeling can be significantly improved, the occurrence of side reactions can be reduced, and the subsequent separation and purification steps can be simplified to directly obtain high-purity labeled products. The applied technology can be widely used in the fields of nuclear medicine imaging, radioactive tracing, tumor targeted therapy, etc., significantly improving the performance and clinical application value of related products.
附图说明BRIEF DESCRIPTION OF THE DRAWINGS
图1为实施例1的Radio-TLC薄层扫描仪扫描曲线图;FIG1 is a Radio-TLC thin layer scanner scanning curve diagram of Example 1;
图2为实施例1的Radio-TLC薄层扫描仪扫描结果;FIG2 is a Radio-TLC thin layer scanner scanning result of Example 1;
图3为实施例2的Radio-TLC薄层扫描仪扫描曲线图;FIG3 is a Radio-TLC thin layer scanner scanning curve diagram of Example 2;
图4为实施例2的Radio-TLC薄层扫描仪扫描结果。FIG. 4 is the scanning result of Radio-TLC thin layer scanner of Example 2.
具体实施方式DETAILED DESCRIPTION
首先,本领域技术人员应当理解的是,这些实施方式仅仅用于解释本申请实施例的技术原理,并非旨在限制本申请实施例的保护范围。本领域技术人员可以根据需要对其作出调整,以便适应具体的应用场合。First, those skilled in the art should understand that these implementations are only used to explain the technical principles of the embodiments of the present application, and are not intended to limit the protection scope of the embodiments of the present application. Those skilled in the art can make adjustments to them as needed to adapt to specific application scenarios.
下面结合附图和具体实施例对本申请作进一步详细说明。The present application is further described in detail below with reference to the accompanying drawings and specific embodiments.
本发明提供了一种硅基树脂类化合物,所述硅基树脂类化合物具有如式(I)所示结构:The present invention provides a silicon-based resin compound, wherein the silicon-based resin compound has a structure as shown in formula (I):
其中,P为树脂,且所述树脂为王氏树脂、氯甲基聚苯乙烯树脂、聚乙二醇树脂中的一种;X为-CH2CH2CH2-、-O(CH2CH2OCH2CH2)nCH2CH2-、-O(CH2CH2OCH2CH2)nCH2CH2O-中的一种,Y为-Me、-Et、-CH(CH3)2、-C(CH3)3中的一种,Ar为芳香烃类基团。Wherein, P is a resin, and the resin is one of Wang resin, chloromethyl polystyrene resin, and polyethylene glycol resin; X is one of -CH 2 CH 2 CH 2 -, -O(CH 2 CH 2 OCH 2 CH 2 ) n CH 2 CH 2 -, and -O(CH 2 CH 2 OCH 2 CH 2 ) n CH 2 CH 2 O-; Y is one of -Me, -Et, -CH(CH 3 ) 2 , and -C(CH 3 ) 3 ; and Ar is an aromatic hydrocarbon group.
本发明中的硅基树脂类化合物具有以下优点:The silicone-based resin compound of the present invention has the following advantages:
作为优选的方案,所述芳香烃类基团为 As a preferred embodiment, the aromatic hydrocarbon group is
中的一种。 One of them.
作为优选的方案,所述硅基树脂类化合物的聚合度小于4000。As a preferred solution, the polymerization degree of the silicone-based resin compound is less than 4000.
本发明要解决的第二个技术问题是,提供一种硅基树脂类化合物的制备方法,以解决常规制备方法步骤繁琐且成本高的问题。The second technical problem to be solved by the present invention is to provide a method for preparing a silicone-based resin compound to solve the problem that the conventional preparation method has complicated steps and high costs.
为了解决上述技术问题,本发明提供了一种所述的硅基树脂类化合物的制备方法,所述制备方法包括:In order to solve the above technical problems, the present invention provides a method for preparing the silicone-based resin compound, the preparation method comprising:
S1:取含P树脂的第一化合物经取代反应后得到第二化合物;S1: taking a first compound containing a P resin and subjecting it to a substitution reaction to obtain a second compound;
S2:将所述第二化合物经过至少一次的加成和/或取代加成反应后得到第三化合物;S2: subjecting the second compound to at least one addition and/or substitution addition reaction to obtain a third compound;
S3:将所述第三化合物与芳基卤代物经催化偶联反应后得到硅基树脂类化合物。S3: subjecting the third compound to a catalytic coupling reaction with an aromatic halide to obtain a silicon-based resin compound.
在一种可能的实施方式中,所述第一化合物为氯甲基聚苯乙烯树脂,所述制备方法包括:In a possible embodiment, the first compound is chloromethyl polystyrene resin, and the preparation method comprises:
S1:树脂a与氯丙烯镁经取代反应得化合物b;S1: Resin a and magnesium chloride are reacted by substitution to obtain compound b;
S2:化合物b与硅烷经加成反应得化合物c;S2: Compound b reacts with silane to obtain compound c;
S3:化合物c与芳基卤代物经催化偶联反应得硅基树脂类化合物d,即为所述硅基树脂类化合物;S3: Compound c and an aromatic halide are subjected to a catalytic coupling reaction to obtain a silicon-based resin compound d, which is the silicon-based resin compound;
所述制备方法的反应过程如下:The reaction process of the preparation method is as follows:
式中,Z为Cl、Br、I中的一种,a为树脂a,b为化合物b,c为化合物c,d为硅基树脂类化合物d。In the formula, Z is one of Cl, Br, and I, a is resin a, b is compound b, c is compound c, and d is silicon-based resin compound d.
作为优选的方案,所述第一化合物为王氏树脂,所述制备方法包括:As a preferred solution, the first compound is Wang resin, and the preparation method comprises:
S1:树脂e与三苯基溴化膦经取代反应得化合物f;S1: Resin e and triphenylphosphine bromide undergo substitution reaction to obtain compound f;
S2:化合物f与氯丙烯镁经取代加成反应得化合物g,化合物g与二烷基硅烷经加成反应得化合物h;S2: Compound f is reacted with magnesium chloride to obtain compound g through substitution addition reaction, and compound g is reacted with dialkylsilane to obtain compound h through addition reaction;
S3:化合物h与芳基卤代物经催化偶联反应得硅基树脂类化合物i;S3: Compound h and aryl halide undergo catalytic coupling reaction to obtain silicone-based resin compound i;
所述制备方法的反应过程如下:The reaction process of the preparation method is as follows:
式中,Z为Cl、Br、I中的一种,e为树脂e,f为反应物f,g为化合物g,h为化合物h,i为硅基树脂类化合物i。In the formula, Z is one of Cl, Br, and I, e is resin e, f is reactant f, g is compound g, h is compound h, and i is silicon-based resin compound i.
作为优选的方案,所述第一化合物为王氏树脂或氯甲基聚苯乙烯树脂,所述制备方法包括:As a preferred solution, the first compound is Wang resin or chloromethyl polystyrene resin, and the preparation method comprises:
S1:树脂j与聚乙二醇经取代反应得化合物k;S1: Resin j and polyethylene glycol undergo substitution reaction to obtain compound k;
S2:化合物k与二氯亚砜经取代加成反应得化合物l;化合物l与氯丙烯镁经取代反应得化合物m;化合物m与二烷基硅烷经加成反应得化合物n;S2: Compound k is reacted with thionyl chloride to obtain compound l through substitution and addition reaction; compound l is reacted with magnesium chloride to obtain compound m through substitution reaction; compound m is reacted with dialkylsilane to obtain compound n through addition reaction;
S3:化合物n与芳基卤代物经催化偶联反应得硅基树脂类化合物o;其中n<4000,为树脂,选自:王氏树脂,氯甲基聚苯乙烯树脂,Z选自:Cl,Br,I,Y指代同权利要求1所述,Ar指代同权利要求1所述;S3: Compound n is reacted with an aromatic halide by catalytic coupling reaction to obtain a silicon-based resin compound o; wherein n<4000, is a resin selected from: Wang resin, chloromethyl polystyrene resin, Z is selected from: Cl, Br, I, Y refers to the same as described in claim 1, and Ar refers to the same as described in claim 1;
所述制备方法的反应过程如下:The reaction process of the preparation method is as follows:
式中,Z为Cl、Br、I中的一种,j为树脂j,k为化合物k,l为化合物l,m为化合物m,n为化合物n,o为硅基树脂类化合物o。In the formula, Z is one of Cl, Br, and I, j is resin j, k is compound k, l is compound l, m is compound m, n is compound n, and o is silicone-based resin compound o.
作为优选的方案,所述第一化合物为聚乙二醇树脂,所述制备方法包括:As a preferred solution, the first compound is a polyethylene glycol resin, and the preparation method comprises:
S1:树脂p与二氯亚砜经取代反应得化合物q;S1: Resin p reacts with thionyl chloride to obtain compound q;
S2:化合物q与氯丙烯镁经取代加成反应得化合物r;化合物r与二烷基硅烷经取代反应得化合物s;S2: Compound q reacts with magnesium chloride to obtain compound r through substitution addition reaction; compound r reacts with dialkylsilane to obtain compound s through substitution reaction;
S3:化合物s与芳基卤代物经催化偶联反应得硅基树脂类化合物t;S3: Compound s reacts with an aromatic halide through a catalytic coupling reaction to obtain a silicone-based resin compound t;
所述制备方法的反应过程如下:The reaction process of the preparation method is as follows:
其中,P为聚乙二醇树脂,Z为Cl、Br、I中的一种,p为树脂p,q为化合物q,r为化合物r,s为化合物s,t为硅基树脂类化合物t。Wherein, P is polyethylene glycol resin, Z is one of Cl, Br, and I, p is resin p, q is compound q, r is compound r, s is compound s, and t is silicon-based resin compound t.
本发明要解决第三个技术问题是,提供上述硅基树脂类化合物的应用,以解决常规放射性标记中存在的反应条件苛刻、放射化学产率低、副反应多以及容易对待标记物造成破坏的问题。The third technical problem to be solved by the present invention is to provide the application of the above-mentioned silicon-based resin compounds to solve the problems of harsh reaction conditions, low radiochemical yield, many side reactions and easy damage to the labeled substance in conventional radioactive labeling.
为了解决上述问题,本发明提供了一种所述硅基树脂类化合物的应用,所述应用包括将该硅基树脂类化合物应用于放射性标记中包括:将所述硅基树脂类化合物与131I/124I/127I/211At-发生亲电取代反应,制得芳基碘化合物或芳基砹化合物,随后,通过过滤分离标记产物,完成放射性标记。In order to solve the above problems, the present invention provides an application of the silicon-based resin compound, and the application includes applying the silicon-based resin compound to radioactive labeling, including: subjecting the silicon-based resin compound to an electrophilic substitution reaction with 131 I/ 124 I/ 127 I/ 211 At- to obtain an aryl iodine compound or an aryl astatine compound, and then separating the labeled product by filtration to complete the radioactive labeling.
作为优选的方案,所述反应的条件为:温度20-50℃,pH5.0-7.0。As a preferred solution, the reaction conditions are: temperature 20-50°C, pH 5.0-7.0.
以下,结合具体的实验数据以及操作手段,提供实施例,以对本发明上述的技术方案进行进一步地展开:In the following, in combination with specific experimental data and operating methods, embodiments are provided to further expand the above technical solutions of the present invention:
实施例1Example 1
本实施例提供了一种硅基树脂类化合物3及其制备方法,其制备的反应过程的反应式如下:This embodiment provides a silicon-based resin compound 3 and a preparation method thereof, and the reaction formula of the preparation process is as follows:
制备方法包括:The preparation method comprises:
S1:化合物1的合成步骤:S1: Synthesis steps of compound 1:
将2.0g氯甲基聚苯乙烯树脂置于反应瓶中,氮气保护下加入20mL无水甲苯后,室温搅拌10分钟,随后将10mL氯丙烯镁(2.0M in the THF)逐滴滴加到反应瓶中反应30分钟后,再升温至60℃反应12小时,反应结束后抽滤,滤渣用四氢呋喃洗涤三次,随后将滤渣置于反应瓶中,并加入22.5mL四氢呋喃,并在搅拌中加入7.5mL 1N盐酸溶液,加入完毕后将反应温度升至45℃,反应12小时,反应结束后抽滤,滤渣分别用甲醇和二氯甲烷洗涤三次,随后真空干燥。2.0 g of chloromethyl polystyrene resin was placed in a reaction bottle, 20 mL of anhydrous toluene was added under nitrogen protection, and the mixture was stirred at room temperature for 10 minutes. Subsequently, 10 mL of allyl magnesium chloride (2.0 M in the THF) was added dropwise into the reaction bottle and reacted for 30 minutes. The mixture was then heated to 60°C and reacted for 12 hours. After the reaction was completed, the mixture was filtered and the filter residue was washed three times with tetrahydrofuran. Subsequently, the filter residue was placed in a reaction bottle, 22.5 mL of tetrahydrofuran was added, and 7.5 mL of 1N hydrochloric acid solution was added during stirring. After the addition was completed, the reaction temperature was raised to 45°C and the mixture was reacted for 12 hours. After the reaction was completed, the mixture was filtered and the filter residue was washed three times with methanol and dichloromethane, respectively, and then dried in vacuo.
化合物1的红外数据:1640cm-1(C=C)。Infrared data of Compound 1: 1640 cm -1 (C=C).
S2:化合物2的合成步骤:S2: Synthesis steps of compound 2:
将2.0g化合物1置于反应瓶中,随后加入18.5mg RhCl(PPh3)3,并在氮气保护下加入20mL无水甲苯在室温下反应5分钟,随后加入1.6mL二乙基硅烷,并在室温下反应12小时,反应结束后抽滤,滤渣分别用乙酸乙酯和二氯甲烷洗涤三次,随后真空干燥。2.0 g of compound 1 was placed in a reaction bottle, followed by the addition of 18.5 mg of RhCl(PPh 3 ) 3 , and under nitrogen protection, 20 mL of anhydrous toluene was added to react at room temperature for 5 minutes, followed by the addition of 1.6 mL of diethylsilane, and the reaction was carried out at room temperature for 12 hours. After the reaction was completed, the filter was filtered, and the residue was washed three times with ethyl acetate and dichloromethane, respectively, and then dried in vacuo.
化合物2的红外数据:2110cm-1(Si-H),1230cm-1(Si-C)。Infrared data of compound 2: 2110 cm -1 (Si-H), 1230 cm -1 (Si-C).
S3:化合物3的合成步骤:S3: Synthesis steps of compound 3:
将500mg化合物2置于反应瓶中,加入286mg(3-溴苄基)氨基甲酸叔丁酯,295mg乙酸钾,91mg三(邻甲基苯基)膦,52mg三(二亚苄基丙酮)二钯(0)-氯仿加合物,并在氮气保护下加入10mLN-甲基吡咯烷酮,并在125℃下反应20小时,反应结束后抽滤,滤渣分别用N,N-二甲基甲酰胺,1N盐酸溶液,甲醇,二氯甲烷洗涤三次,随后真空干燥。500 mg of compound 2 was placed in a reaction bottle, and 286 mg of tert-butyl (3-bromobenzyl)carbamate, 295 mg of potassium acetate, 91 mg of tri(o-methylphenyl)phosphine, and 52 mg of tri(dibenzylideneacetone)dipalladium(0)-chloroform adduct were added. 10 mL of N-methylpyrrolidone was added under nitrogen protection, and the mixture was reacted at 125°C for 20 hours. After the reaction was completed, the mixture was filtered and the residue was washed three times with N,N-dimethylformamide, 1N hydrochloric acid solution, methanol, and dichloromethane, respectively, and then dried in vacuo.
化合物3的红外数据:3450cm-1(N-H)。Infrared data of compound 3: 3450 cm -1 (NH ).
实施例2Example 2
本实施例提供了硅基树脂类化合物3及其制备方法,其制备的反应过程的反应式如下:This embodiment provides a silicon-based resin compound 3 and a preparation method thereof, and the reaction formula of the preparation process thereof is as follows:
制备方法包括:The preparation method comprises:
S1:化合物4的合成步骤:S1: Synthesis steps of compound 4:
将4.0g氯甲基聚苯乙烯树脂置于反应瓶中,加入40mL 1,4-二氧六环,随后室温滴加35g聚乙二醇(聚乙二醇-400)和100mL33%氢氧化钠的水溶液的混合溶液,滴加完毕后升温至50℃,并反应10小时,反应结束后抽滤,滤渣分别用水,1N盐酸溶液,水,甲醇和二氯甲烷洗涤三次,随后真空干燥。4.0 g of chloromethyl polystyrene resin was placed in a reaction bottle, 40 mL of 1,4-dioxane was added, and then a mixed solution of 35 g of polyethylene glycol (polyethylene glycol-400) and 100 mL of 33% sodium hydroxide aqueous solution was added dropwise at room temperature. After the addition was completed, the temperature was raised to 50°C and reacted for 10 hours. After the reaction was completed, the filter was filtered and the residue was washed three times with water, 1N hydrochloric acid solution, water, methanol and dichloromethane, respectively, and then vacuum dried.
化合物4的红外数据:3200cm-1(O-H)。Infrared data of compound 4: 3200 cm -1 (OH).
S2:化合物5的合成步骤:S2: Synthesis steps of compound 5:
将1.5g化合物4置于反应瓶中,加入10mL二氯亚砜,随后在100℃条件下反应12小时,反应结束后抽滤,滤渣分别用二氯甲烷,甲醇和二氯甲烷洗涤三次,随后真空干燥。1.5 g of compound 4 was placed in a reaction bottle, and 10 mL of dichlorothionyl was added, followed by reaction at 100° C. for 12 hours. After the reaction was completed, the filter was filtered and the residue was washed three times with dichloromethane, methanol and dichloromethane respectively, and then dried in vacuum.
化合物5的红外数据:760cm-1(C-Cl)。Infrared data of compound 5: 760 cm -1 (C-Cl).
化合物6的合成步骤:Synthesis steps of compound 6:
将1.5g氯甲基聚苯乙烯树脂置于反应瓶中,氮气保护下加入20mL无水甲苯后,室温搅拌10分钟,随后将10mL氯丙烯镁(2.0M in the THF)逐滴滴加到反应瓶中反应30分钟后,再升温至60℃反应12小时,反应结束后抽滤,滤渣用四氢呋喃洗涤三次,随后将滤渣置于反应瓶中,并加入22.5mL四氢呋喃,并在搅拌中加入7.5mL 1N盐酸溶液,加入完毕后将反应温度升至45℃,反应12小时,反应结束后抽滤,滤渣分别用甲醇和二氯甲烷洗涤三次,随后真空干燥。1.5 g of chloromethyl polystyrene resin was placed in a reaction bottle, 20 mL of anhydrous toluene was added under nitrogen protection, and the mixture was stirred at room temperature for 10 minutes. Subsequently, 10 mL of allyl magnesium chloride (2.0 M in the THF) was added dropwise into the reaction bottle and reacted for 30 minutes. The mixture was then heated to 60°C and reacted for 12 hours. After the reaction was completed, the mixture was filtered and the residue was washed three times with tetrahydrofuran. Subsequently, the residue was placed in a reaction bottle, 22.5 mL of tetrahydrofuran was added, and 7.5 mL of 1N hydrochloric acid solution was added during stirring. After the addition was completed, the reaction temperature was raised to 45°C and the mixture was reacted for 12 hours. After the reaction was completed, the mixture was filtered and the residue was washed three times with methanol and dichloromethane, respectively, and then dried in vacuo.
化合物6的红外数据:1639cm-1(C=C)。Infrared data of compound 6: 1639 cm -1 (C=C).
化合物7的合成步骤:Synthesis steps of compound 7:
将1.5g化合物6置于反应瓶中,随后加入18.5mg RhCl(PPh3)3,并在氮气保护下加入20mL无水甲苯在室温下反应5分钟,随后加入1.6mL二乙基硅烷,并在室温下反应12小时,反应结束后抽滤,滤渣分别用乙酸乙酯和二氯甲烷洗涤三次,随后真空干燥。1.5 g of compound 6 was placed in a reaction bottle, followed by the addition of 18.5 mg of RhCl(PPh 3 ) 3 , and under nitrogen protection, 20 mL of anhydrous toluene was added to react at room temperature for 5 minutes, followed by the addition of 1.6 mL of diethylsilane, and the reaction was continued at room temperature for 12 hours. After the reaction was completed, the filter was filtered, and the residue was washed three times with ethyl acetate and dichloromethane, respectively, and then dried in vacuo.
化合物6的红外数据:2107cm-1(Si-H),1232cm-1(Si-C)。Infrared data of compound 6: 2107 cm -1 (Si-H), 1232 cm -1 (Si-C).
S3:化合物7的合成步骤:S3: Synthesis steps of compound 7:
将500mg化合物7置于反应瓶中,加入286mg(3-溴苄基)氨基甲酸叔丁酯,295mg乙酸钾,91mg三(邻甲基苯基)膦,52mg三(二亚苄基丙酮)二钯(0)-氯仿加合物,并在氮气保护下加入10mLN-甲基吡咯烷酮,并在125℃下反应20小时,反应结束后抽滤,滤渣分别用N,N-二甲基甲酰胺,1N盐酸溶液,甲醇,二氯甲烷洗涤三次,随后真空干燥。500 mg of compound 7 was placed in a reaction bottle, and 286 mg of tert-butyl (3-bromobenzyl)carbamate, 295 mg of potassium acetate, 91 mg of tri(o-methylphenyl)phosphine, and 52 mg of tri(dibenzylideneacetone)dipalladium(0)-chloroform adduct were added. 10 mL of N-methylpyrrolidone was added under nitrogen protection, and the mixture was reacted at 125°C for 20 hours. After the reaction was completed, the mixture was filtered and the residue was washed three times with N,N-dimethylformamide, 1N hydrochloric acid solution, methanol, and dichloromethane, respectively, and then dried in vacuo.
化合物7的红外数据:3440cm-1(N-H)。Infrared data of compound 7: 3440 cm -1 (NH ).
以下提供本发明中上述实施例1制备得到的硅基树脂类化合物的应用,所述应用包括将该硅基树脂类化合物应用于[131I]NaI的标记。The following provides an application of the silicon-based resin compound prepared in Example 1 of the present invention, wherein the application includes applying the silicon-based resin compound to labeling [ 131 I]NaI.
放射性标记实验1:Radiolabeling experiment 1:
反应过程包括:The reaction process includes:
具体为:将[131I]NaI(200μCi,200μLMeOH)加入含10毫克标记树脂前体的西林瓶中。然后向西林瓶中加入20μLN-氯代丁二酰亚胺的冰醋酸溶液(0.3M),并在室温下搅拌30分钟,反应结束后加入40μL饱和亚硫酸钠溶液。使用铝制硅胶板(展开剂,石油醚:乙酸乙酯=10:1)进行展开,并用Radio-TLC薄层扫描仪扫描,测得RCC为6%。Specifically, [ 131I ]NaI (200μCi, 200μLMeOH) was added to a vial containing 10 mg of labeled resin precursor. Then, 20μL of N-chlorosuccinimide glacial acetic acid solution (0.3M) was added to the vial and stirred at room temperature for 30 minutes. After the reaction was completed, 40μL of saturated sodium sulfite solution was added. Aluminum silica gel plates (developing agent, petroleum ether: ethyl acetate = 10:1) were used for development and scanned with a Radio-TLC thin layer scanner, and the RCC was measured to be 6%.
放射性标记实验2:Radiolabeling experiment 2:
反应过程包括:The reaction process includes:
具体为:将[131I]NaI(200μCi,200μLMeOH)加入含10毫克标记树脂前体的西林瓶中。然后向西林瓶中加入20μLN-氯代丁二酰亚胺的冰醋酸溶液(0.3M),并在室温下搅拌30分钟,反应结束后加入40μL饱和亚硫酸钠溶液。使用铝制硅胶板(展开剂,石油醚:乙酸乙酯=10:1)进行展开,并用Radio-TLC薄层扫描仪扫描,测得RCC为16%。Specifically, [ 131I ]NaI (200μCi, 200μLMeOH) was added to a vial containing 10 mg of labeled resin precursor. Then, 20μL of N-chlorosuccinimide glacial acetic acid solution (0.3M) was added to the vial and stirred at room temperature for 30 minutes. After the reaction, 40μL of saturated sodium sulfite solution was added. Aluminum silica gel plates (developing agent, petroleum ether: ethyl acetate = 10:1) were used for development and scanned with a Radio-TLC thin layer scanner, and the RCC was measured to be 16%.
如图1-图4所示,图1为实施例1的Radio-TLC薄层扫描仪扫描曲线图;图2为实施例1的Radio-TLC薄层扫描仪扫描结果;图3为实施例2的Radio-TLC薄层扫描仪扫描曲线图;As shown in Figures 1 to 4, Figure 1 is a scanning curve diagram of the Radio-TLC thin layer scanner of Example 1; Figure 2 is a scanning result of the Radio-TLC thin layer scanner of Example 1; Figure 3 is a scanning curve diagram of the Radio-TLC thin layer scanner of Example 2;
图4为实施例2的Radio-TLC薄层扫描仪扫描结果,图1-4也是进一步地证明了,本发明相较于之前的标记方法来讲,实现了无需HPLC分离的优势,可以避免放射性核素在分离过程中的长时间暴露。FIG4 is the scanning result of the Radio-TLC thin layer scanner of Example 2. FIG1-4 further proves that, compared with the previous labeling method, the present invention achieves the advantage of not requiring HPLC separation and can avoid long-term exposure of radionuclides during the separation process.
在本申请实施例的描述中,需要说明的是,在本申请的描述中,术语“内”、“外”等指示的方向或位置关系的术语是基于附图所示的方向或位置关系,这仅仅是为了便于描述,而不是指示或暗示所述装置或构件必须具有特定的方位、以特定的方位构造和操作,因此不能理解为对本申请的限制。In the description of the embodiments of the present application, it should be noted that in the description of the present application, terms such as "inside" and "outside" indicating directions or positional relationships are based on the directions or positional relationships shown in the drawings. This is only for the convenience of description, and does not indicate or imply that the device or component must have a specific orientation, be constructed and operated in a specific orientation. Therefore, it cannot be understood as a limitation on the present application.
在本申请的描述中,参考术语“一个实施例”、“一些实施例”、“在本实施例中”、“具体示例”、或“一些示例”等的描述意指结合该实施例或示例描述的具体特征、机构、材料或者特点包含于本申请的至少一个实施例或示例中。在本说明书中,对上述术语的示意性表述不必须针对的是相同的实施例或示例。而且,描述的具体特征、机构、材料或者特点可以在任一个或多个实施例或示例中以合适的方式结合。此外,在不相互矛盾的情况下,本领域的技术人员可以将本说明书中描述的不同实施例或示例以及不同实施例或示例的特征进行结合和组合。In the description of the present application, the description with reference to the terms "one embodiment", "some embodiments", "in the present embodiment", "specific example", or "some examples" etc. means that the specific features, mechanisms, materials or characteristics described in conjunction with the embodiment or example are included in at least one embodiment or example of the present application. In this specification, the schematic representations of the above terms do not necessarily refer to the same embodiment or example. Moreover, the specific features, mechanisms, materials or characteristics described may be combined in a suitable manner in any one or more embodiments or examples. In addition, those skilled in the art may combine and combine the different embodiments or examples described in this specification and the features of the different embodiments or examples, without contradiction.
以上所述,仅为本申请的具体实施方式,但本申请的保护范围并不局限于此,任何熟悉本技术领域的技术人员在本申请揭露的技术范围内,可轻易想到的变化或替换,都应涵盖在本申请的保护范围之内。因此,本申请的保护范围应以权利要求的保护范围为准。The above is only a specific implementation of the present application, but the protection scope of the present application is not limited thereto. Any changes or substitutions that can be easily thought of by a person skilled in the art within the technical scope disclosed in the present application should be included in the protection scope of the present application. Therefore, the protection scope of the present application shall be based on the protection scope of the claims.
Claims (10)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202410962333.6A CN118909162B (en) | 2024-07-18 | 2024-07-18 | A silicon-based resin compound and its preparation method and application |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202410962333.6A CN118909162B (en) | 2024-07-18 | 2024-07-18 | A silicon-based resin compound and its preparation method and application |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN118909162A true CN118909162A (en) | 2024-11-08 |
| CN118909162B CN118909162B (en) | 2025-07-11 |
Family
ID=93311626
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202410962333.6A Active CN118909162B (en) | 2024-07-18 | 2024-07-18 | A silicon-based resin compound and its preparation method and application |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN118909162B (en) |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20010024798A1 (en) * | 1998-06-11 | 2001-09-27 | Shair Matthew D. | Biomimetic combinatorial synthesis |
| CN102675500A (en) * | 2011-03-07 | 2012-09-19 | 深圳英利华生物技术有限公司 | Method for preparing polymer-supported organotin compound by using organic magneson and application of organotin compound |
| CN104558001A (en) * | 2014-12-22 | 2015-04-29 | 北京智博高科生物技术有限公司 | Silicon-labelled precursor compound as well as preparation method and application thereof |
-
2024
- 2024-07-18 CN CN202410962333.6A patent/CN118909162B/en active Active
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20010024798A1 (en) * | 1998-06-11 | 2001-09-27 | Shair Matthew D. | Biomimetic combinatorial synthesis |
| CN102675500A (en) * | 2011-03-07 | 2012-09-19 | 深圳英利华生物技术有限公司 | Method for preparing polymer-supported organotin compound by using organic magneson and application of organotin compound |
| CN104558001A (en) * | 2014-12-22 | 2015-04-29 | 北京智博高科生物技术有限公司 | Silicon-labelled precursor compound as well as preparation method and application thereof |
Also Published As
| Publication number | Publication date |
|---|---|
| CN118909162B (en) | 2025-07-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US8114381B2 (en) | Radiolabeled compounds and compositions, their precursors and methods for their production | |
| Lee et al. | Nickel-mediated oxidative fluorination for PET with aqueous [18F] fluoride | |
| Mushtaq et al. | Critical analysis of radioiodination techniques for micro and macro organic molecules | |
| JPWO2019027059A1 (en) | Method for Producing Radiolabeled Aryl Compound | |
| US20060083677A1 (en) | Solid-phase fluorination of benzothiazoles | |
| Zhang et al. | Highly efficient and stable strain-release radioiodination for thiol chemoselective bioconjugation | |
| WO2021244529A1 (en) | Radiolabeled boron-containing compound, preparation method and application | |
| JP2006510707A (en) | Solid phase fluorination of uracil and cytosine | |
| CN118909162A (en) | Silicon-based resin compound and preparation method and application thereof | |
| Li et al. | Organic syntheses on an icosahedral borane surface: Closomer structures with twelvefold functionality | |
| KR100825295B1 (en) | Ionic liquid crown ether derivatives, preparation method thereof and separation method of metal ions using the same | |
| CN105963724B (en) | A kind of radiolabeled tumor developer, preparation method and application | |
| CN102126985B (en) | 18F labelled precursor compound and preparation method and application thereof | |
| CN116239498B (en) | The method for preparing crisborole intermediate | |
| CN114656390A (en) | Synthetic method of 18F-labeled benzamide dopamine receptor imaging agent | |
| US20230355813A1 (en) | Theranostic Silicon-Fluoride Heteroaromatic Systems and Methods Thereof | |
| CN108586524B (en) | Fluoro phosphine oxide-type compound and its application in positron emission imaging | |
| CN117700479A (en) | Targeted prostate specific membrane antigen inhibitor, radioactive marker, preparation method and application thereof | |
| CN106084004B (en) | 18F click-labeled transferrin receptor targeting polypeptide T7 as well as preparation method and application thereof | |
| CN112390760B (en) | FAK-targeting compound and preparation method and application thereof | |
| CN113105432B (en) | A carbon-11 (11C) radiopharmaceutical and its preparation method and application | |
| WO2024021556A1 (en) | Radioactive metal complex targeting prostate specific membrane antigen and labeling ligand thereof | |
| CN115010739A (en) | Method for synthesizing F-BPA | |
| CN112341464A (en) | Halogen-substituted Latricinib compound | |
| CN100398538C (en) | A kind of preparation method of N-2-fluoroethyl-2β-methoxyl-3β-(4-chlorophenyl) demethyltropane |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| GR01 | Patent grant | ||
| GR01 | Patent grant |